资讯

Incyte (INCY) “announced that the FDA has approved Opzelura cream 1.5%, a topical Janus kinase inhibitor, for the short-term and non-continuous ...
The Knights hope to wrap up their nonconference slate undefeated before opening Big 12 play next week against Kansas State.